These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2548865

  • 1. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL, Thornsberry C, Gavan TL.
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
    [Abstract] [Full Text] [Related]

  • 2. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC, Jones RN, Barry AL, Gavan TL.
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [Abstract] [Full Text] [Related]

  • 3. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
    Barry AL, Pfaller MA, Fuchs PC.
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
    [Abstract] [Full Text] [Related]

  • 4. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
    Jones RN, Barry AL.
    J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
    [Abstract] [Full Text] [Related]

  • 5. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
    Jones RN, Doern GV, Gerlach EH, Hindler J, Erwin ME.
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
    [Abstract] [Full Text] [Related]

  • 6. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH, Swenson JM, Tenover FC, Barry A, Ferraro MJ, Murray PR, Reller LB.
    J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
    [Abstract] [Full Text] [Related]

  • 7. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL, Jones RN.
    J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
    [Abstract] [Full Text] [Related]

  • 8. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
    Barry AL, Jones RN, Gavan TL, Thornsberry C.
    J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
    [Abstract] [Full Text] [Related]

  • 9. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
    Barry A, Fuchs P, Tenover F, Allen S, Hardy D, Jorgensen J, McLaughlin J, Reller L.
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility testing quality control studies with fosfomycin tromethamine.
    Fuchs PC, Barry AL, Brown SD.
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
    [Abstract] [Full Text] [Related]

  • 11. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
    Barry AL, Pfaller MA, Fuchs PC, Tenover FC, Reller LB, Allen SD, Hardy DJ, Gerlach EH.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
    [Abstract] [Full Text] [Related]

  • 12. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
    Jones RN, Barry AL, Fuchs PC, Thornsberry C.
    J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
    [Abstract] [Full Text] [Related]

  • 13. Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
    Barry AL, Fuchs PC, Allen SD, Tenover FC, Jorgensen JH, Reller LB.
    J Clin Microbiol; 1995 Jan; 33(1):235-8. PubMed ID: 7699050
    [Abstract] [Full Text] [Related]

  • 14. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
    Barry AL, Thornsberry C, Jones RN, Gavan TL.
    J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833
    [Abstract] [Full Text] [Related]

  • 15. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
    Barry AL, Jones RN, Gavan TL.
    J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
    Jones RN, Erwin ME.
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM, Stoneburner A, Shinabarger DL, Abbeloos E, Goby L, Bradley AJ.
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Provisional quality control parameters and interpretive criteria for testing susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to quinupristin/dalfopristin (RP59500). Antimicrobial Testing Quality Control Group.
    Fuchs P, Barry A, Brown S.
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):197-201. PubMed ID: 9665303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.